The Sandarazols are Cryptic and Structurally Unique Plasmid‐Encoded Toxins from a Rare Myxobacterium**
Open Access
- 3 February 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (15) , 8081-8088
Abstract
Herein, we describe a new plasmid found in Sandaracinus sp. MSr10575 named pSa001 spanning 209.7 kbp that harbors a cryptic secondary metabolite biosynthesis gene cluster (BGC). Activation of this BGC by homologous‐recombination‐mediated exchange of the native promoter sequence against a vanillate inducible system led to the production and subsequent isolation and structure elucidation of novel secondary metabolites, the sandarazols A–G. The sandarazols contain intriguing structural features and very reactive functional groups such as an α‐chlorinated ketone, an epoxyketone, and a (2R)‐2‐amino‐3‐(N,N‐dimethylamino)‐propionic acid building block. In‐depth investigation of the underlying biosynthetic machinery led to a concise biosynthetic model for the new compound family, including several uncommon biosynthetic steps. The chlorinated congener sandarazol C shows an IC50 value of 0.5 μm against HCT 116 cells and a MIC of 14 μm against Mycobacterium smegmatis, which points at the sandarazols’ potential function as defensive secondary metabolites or toxins.Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolitesBiotechnology Advances, 2020
- Estimating the burden of antimicrobial resistance: a systematic literature reviewAntimicrobial Resistance & Infection Control, 2018
- Natural Products as Sources of New Drugs from 1981 to 2014Journal of Natural Products, 2016
- Characterization of novel conjugative multiresistance plasmids carryingcfrfrom linezolid-resistantStaphylococcus epidermidisclinical isolates from ItalyJournal of Antimicrobial Chemotherapy, 2015
- Horizontal gene transfer: building the web of lifeNature Reviews Genetics, 2015
- Natural products: A continuing source of novel drug leadsBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Insights into a Divergent Phenazine Biosynthetic Pathway Governed by a Plasmid-Born Esmeraldin Gene ClusterChemistry & Biology, 2012
- Myxobacteria—‘microbial factories’ for the production of bioactive secondary metabolitesMolecular BioSystems, 2009
- Bacillus anthracis Virulent Plasmid pX02 Genes Found in Large Plasmids of Two Other Bacillus SpeciesJournal of Clinical Microbiology, 2006
- Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulceransProceedings of the National Academy of Sciences, 2004